Jose Antonio
Sánchez Alcazar
Centro Andaluz de Biología del Desarrollo
Sevilla, EspañaPublications in collaboration with researchers from Centro Andaluz de Biología del Desarrollo (41)
2024
-
A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models
Antioxidants, Vol. 13, Núm. 8
-
Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation
Biomolecules, Vol. 14, Núm. 5
-
The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution
Functional and Integrative Genomics, Vol. 24, Núm. 4
2023
-
Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies
Antioxidants, Vol. 12, Núm. 12
-
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
Biomolecules, Vol. 13, Núm. 12
-
Neurodegeneration, Mitochondria, and Antibiotics
Metabolites, Vol. 13, Núm. 3
-
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
Pharmaceuticals, Vol. 16, Núm. 10
-
Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
Neural Regeneration Research, Vol. 18, Núm. 6, pp. 1196-1202
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
Biomedicines, Vol. 10, Núm. 7
-
Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming
Cellular reprogramming, Vol. 24, Núm. 5, pp. 294-303
-
Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
Frontiers in Pharmacology, Vol. 13
-
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 311
2021
-
Coenzyme q10 analogues: Benefits and challenges for therapeutics
Antioxidants, Vol. 10, Núm. 2, pp. 1-20
-
EGFR-targeting antitumor therapy: Neuregulins or antibodies?
European Journal of Pharmaceutical Sciences, Vol. 158
-
From mitochondria to atherosclerosis: The inflammation path
Biomedicines, Vol. 9, Núm. 3, pp. 1-24
-
Mitochondria and antibiotics: For good or for evil?
Biomolecules, Vol. 11, Núm. 7
2020
-
Coenzyme q10: Novel formulations and medical trends
International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-23
-
Mitochondrial imbalance as a new approach to the study of fibromyalgia
Open Access Rheumatology: Research and Reviews, Vol. 12, pp. 175-185
2019
-
Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 5, pp. 861-881